Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.7210
-0.0342 (-4.53%)
At close: Mar 28, 2025, 4:00 PM
0.7279
+0.0069 (0.95%)
Pre-market: Mar 31, 2025, 8:39 AM EDT

Seres Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1261421816987652,236
Upgrade
Market Cap Growth
-21.59%-21.59%-74.06%-8.81%-65.78%825.56%
Upgrade
Enterprise Value
1871692235414611,979
Upgrade
Last Close Price
0.720.831.405.608.3324.50
Upgrade
PE Ratio
824.001043.26----
Upgrade
PS Ratio
---5.2867.31
Upgrade
PB Ratio
9.0510.29-4.0364.715.8212.79
Upgrade
P/TBV Ratio
10.2910.29-64.715.8212.79
Upgrade
P/OCF Ratio
---114.40-
Upgrade
EV/Sales Ratio
---3.1859.60
Upgrade
Debt / Equity Ratio
6.656.65-4.4315.080.370.23
Upgrade
Asset Turnover
----0.420.14
Upgrade
Quick Ratio
0.800.801.302.123.535.67
Upgrade
Current Ratio
0.940.941.782.283.695.79
Upgrade
Return on Equity (ROE)
----258.04%-42.83%-141.00%
Upgrade
Return on Assets (ROA)
-30.43%-30.43%-34.48%-31.96%-11.55%-23.17%
Upgrade
Return on Capital (ROIC)
-58.47%-58.47%-74.51%-63.51%-20.34%-51.97%
Upgrade
Earnings Yield
0.11%0.10%-62.84%-35.85%-8.57%-3.99%
Upgrade
FCF Yield
-118.52%-105.01%-69.26%-34.20%-0.38%-4.21%
Upgrade
Buyback Yield / Dilution
-21.40%-21.40%-18.44%-17.86%-14.93%-40.85%
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q